Commentary: Hormone Receptor Testing in Breast Cancer: A Distress Signal From Canada

Oncologist - United States
doi 10.1634/theoncologist.2008-0184
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Alphamed Press

Related search

Progesterone Receptor Expression in Proliferating Cancer Cells of Hormone-Receptor-Positive Breast Cancer

Tumor Biology
MedicineCancer Research
2018English

Testing for HER2 in Breast Cancer: Current Pathology Challenges Faced in Canada

Current Oncology
Oncology
2012English

The DEK Oncogene Is a Target of Steroid Hormone Receptor Signaling in Breast Cancer

PLoS ONE
Multidisciplinary
2012English

Hormone Receptors in Breast Cancer

2016English

Factors Determining Anthracycline Use in Hormone Receptor Positive, Early Stage Breast Cancer

Clinical Breast Cancer
Cancer ResearchOncology
2019English

Migraine and Possible Etiologic Heterogeneity for Hormone-Receptor-Negative Breast Cancer

Scientific Reports
Multidisciplinary
2015English

Distress Screening and Management in Early Breast Cancer Patients: Distress After Breast Cancer Diagnosis and Associated Factors

Journal of Breast Disease
2017English

Treatment of Advanced Hormone Receptor-Positive (HR+) HER2-negative Breast Cancer

Geburtshilfe und Frauenheilkunde
GynecologyMidwiferyMaternityObstetrics
2019English

Mammographic Density and Hormone Receptor Expression in Breast Cancer: The Multiethnic Cohort Study

Cancer Epidemiology
Cancer ResearchEpidemiologyOncology
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy